← Evidence map

ReviewCancer science2025

Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine.

Tatsuro Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39837580